Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
diagnosis of type I or II bipolar disorder according to DSM-IV after stratified SCID I interview,
being currently euthimic (for at least one month), manic-hypomanic and having YMRS points of 15 or more, or being in depressive episode and having HAM-D21 points of 15 or more
being not taking drugs for at least two weeks before participating in the study (except benzodiazepins)
You may not be if
female who are pregnant or planning to be pregnant, nursing
having known hypersensitivity to study drug
being given any psychotropic agent other than benzodiazepine within the last two weeks
active sustance or alcohol usage within the last two weeks, or substance addiction other than cafein or nicotine (within the last month)
having another axis I disorder such as comorbid dementia, delirium, obsessive compulsive disorder, eating disorder
having unstabilised hepatic or renal disorder, thyroid or blood disease
having history of cerebral surgery
existence of a degenerative neurologic disease or epilepsy
having pacemaker
having a prosthesis able to magnetic effect in eye, brain or sites near to these regions
homicide thougths or severe catatonia required to be hospitalized
having mixed episode
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
